Trial Profile
A randomised controlled cross-over study of the effect on cognitive function of chronic administration of tolterodine 4 mg od [once daily] in women with overactive bladder
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 21 Jul 2005
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Pharmacodynamics
- 21 Jul 2005 New trial record.